4 Healthcare & Biotech Stocks up over 25% past 10 days
Powered by HealthTechMovers.com
Below is a list of 4 Healthcare & Biotech Stocks up over 25% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
| Ticker | Company | Sector | Previous Close | *Recent Price | % Price Change Past 10 Days |
| NVCT | Nuvectis Pharma | Healthcare & Biotech | $15.87 | $$16.01 | +67% |
Here are 3rd party ratings for NVCT:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Biomea Fusion Inc. is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Biomea Fusion Inc. is based in REDWOOD CITY, Calif.
| Ticker | Company | Sector | Prev Close | *Recent Price | % Price Change Past 10 Days |
| BMEA | Biomea Fusion | Healthcare & Biotech | $4.10 | $4.45 | +34% |
Here are 3rd party ratings for BMEA:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Compass Therapeutics Inc. is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematologic malignancies. The company's lead product candidate includes CTX-471. Compass Therapeutics Inc. is based in Boston, MA.
| Ticker | Company | Sector | Prev Close | *Recent Price | % Price Change Past 10 Days |
| CMPX | Compass Therapeutics | Healthcare & Biotech | $1.84 | $2.10 | +28% |
Here are 3rd party ratings for CMPX:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company. It involved in discovering and developing breakthrough cell therapies to address unmet medical needs in the treatment of cancer. Gracell Biotechnologies Inc. is based in SUZHOU, China.
| Ticker | Company | Sector | Prev Close | *Recent Price | % Price Change Past 10 Days |
| GRCL | Gracell Biotechnologies | Healthcare & Biotech | $2.76 | $3.02 | +25% |
Here are 3rd party ratings for GRCL:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
